Copanlisib in patients with relapsed or refractory follicular lymphoma.

被引：4
|
作者：
Dreyling, Martin H.
Santoro, Armando
Leppa, Sirpa
Demeter, Judit
Follows, George
Lenz, Georg
Kim, Won Seog
Mollica, Luigina
Nagler, Arnon
Diong, Colin Phipps
Provencio, Mariano
Stevens, Don A.
Trevarthen, David
Magagnoli, Massimo
Cupit, Lisa
Yin, Shuxin
Hiemeyer, Florian
-Vargas, Jose E. Garcia
Childs, Barrett H.
Zinzani, Pier Luigi
机构：
[1] Univ Hosp LMU, Munich, Germany
[2] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Rozzano, Italy
[3] Helsinki Univ Cent Hosp, Canc Ctr, Helsinki, Finland
[4] Semmelweis Univ, Div Haematol, Dept Internal Med 1, Budapest, Hungary
[5] Cambridge Univ Hosp, Cambridge, England
[6] Munster Univ Clin, Translat Oncol Med Clin, Munster, Germany
[7] Sungkyunkwan Univ, Div Hematol & Oncol, Samsung Med Ctr, Sch Med, Seoul, South Korea
[8] Hop Maison Neuve Rosemont, Montreal, PQ, Canada
[9] Chaim Sheba Med Ctr, Div Hematol, Tel Hashomer, Israel
[10] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore
[11] Univ Autonoma Madrid, Hlth Res Inst, Hosp Univ Puerta Hierro, Madrid, Spain
[12] Norton Canc Inst, Louisville, KY USA
[13] Comprehens Canc Care & Res Inst, Englewood, CO USA
[14] Bayer HealthCare Pharmaceut Inc, Whippany, NJ USA
[15] Bayer AG, Div Pharmaceut, Berlin, Germany
[16] Univ Bologna, Inst Hematol L eA Seragnoli, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.7535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7535
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
    Ujjani, Chaitra S.
    Lai, Catherine
    Leslie, Lori A.
    Ramzi, Pari
    Tan, Ming
    Wang, Siyu
    Wang, Hongkun
    Shim, Eunice
    Swanson, Nicole
    Broome, Catherine M.
    Gopal, Ajay K.
    Smith, Stephen D.
    Warren, Edus H.
    Blue, Katie
    Kdiry, Sabrina
    Till, Brian G.
    Lynch, Ryan C.
    Shadman, Mazyar
    Johnson, Michael
    Coye, Hilary
    Shelby, Megan
    Tseng, Yolanda D.
    Shustov, Andrei
    Maloney, David G.
    Cheson, Bruce D.
    BLOOD, 2020, 136
  • [22] Novel agents for relapsed and refractory follicular lymphoma
    Cheah, Chan Yoon
    Fowler, Nathan H.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (01) : 41 - 48
  • [23] Updates in Therapies of Relapsed and Refractory Follicular Lymphoma
    Munoz, Javier L.
    ONCOLOGY-NEW YORK, 2021, 35 (08): : 498 - 499
  • [24] LENALIDOMIDE PLUS RITUXIMAB IN ELDERLY PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA
    Della Cioppa, P.
    Lucania, A.
    Esposito, M.
    Improta, S.
    Mastrullo, L.
    HAEMATOLOGICA, 2015, 100 : 151 - 151
  • [25] Estimation of Relapsed/Refractory Follicular Lymphoma Patients on Therapy in the United States
    Johnston, Karissa
    Bennett, Mark
    Chawla, Savreet Bains
    Yang, Shibing
    Wang, Anthony
    Yu, Junhua
    Jun, Monika
    BLOOD, 2023, 142
  • [26] Salvage Treatment with Lenalidomide and Dexamethasone in Patients with Relapsed Refractory Mantle Cell Lymphoma.
    Zaja, Francesco
    De Luca, Stefano
    Vitolo, Umberto
    Orsucci, Lorella
    Levis, Alessandro
    Salvi, Flavia
    Gargantini, Livio
    Ravelli, Erika
    Tucci, Alessandra
    Bottelli, Chiara
    Balzarotti, Monica
    Santoro, Armando
    Brusamolino, Ercole
    Bonfichi, Maurizio
    Di Rocco, Alice
    Stelitano, Caterina
    Baldini, Luca
    Pileri, Stefano Aldo
    Volpetti, Stefano
    Ciccone, Giovannino
    Ferranti, Antonella
    Fanin, Renato
    BLOOD, 2009, 114 (22) : 683 - 683
  • [27] Safety and Tolerability of Conatumumab in Combination with Bortezomib or Vorinostat in Patients with Relapsed or Refractory Lymphoma.
    Younes, Anas
    Kirschbaum, Mark
    Sokol, Lubomir
    Yee, Lorrin
    Romaguera, Jorge
    Goyal, Lovely
    Hsu, Cheng-Pang
    Hwang, Yuying
    Gorski, Kevin
    Wong, Susan
    Beaupre, Darrin M.
    BLOOD, 2009, 114 (22) : 680 - 681
  • [28] Gemcitabine plus rituximab therapy of patients with relapsed and refractory classical Hodgkin lymphoma.
    Younes, A
    Fayad, L
    Pro, B
    Goy, A
    Romaguera, JE
    Hagemeister, FB
    McLaughlin, P
    BLOOD, 2005, 106 (11) : 431A - 431A
  • [29] Interim results of a phase II multicenter study with the oral histone deacetylase inhibitor abexinostat in patients with relapsed/refractory follicular lymphoma.
    Gui, Lin
    Cheng, Ying
    Wang, Huaqing
    Cao, Junning
    Li, Zhenling
    Zhang, Lei
    Gao, Yuhuan
    Li, Yufu
    Xu, Weijie
    Li, Xiang
    Ke, Xiaoyan
    Jing, Hongmei
    Zhang, Qingyuan
    Xi, Yaming
    Liu, Tingbo
    Wang, Zhen
    Gao, Yajie
    Pan, Qin
    Zou, Liqun
    Shi, Yuankai
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma
    Dreyling, Martin
    Santoro, Armando
    Mollica, Luigina
    Leppa, Sirpa
    Follows, George A.
    Lenz, Georg
    Kim, Won Seog
    Nagler, Arnon
    Panayiotidis, Panayiotis
    Demeter, Judit
    Ozcan, Muhit
    Kosinova, Marina
    Bouabdallah, Krimo
    Morschhauser, Franck
    Stevens, Don A.
    Trevarthen, David
    Giurescu, Marius
    Cupit, Lisa
    Liu, Li
    Koechert, Karl
    Seidel, Henrik
    Pena, Carol
    Yin, Shuxin
    Hiemeyer, Florian
    Garcia-Vargas, Jose
    Childs, Barrett H.
    Zinzani, Pier Luigi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (35) : 3898 - +
12345